Brought to you by 
Aegerion Pharmaceuticals raises funds
Sep 2008
Executive Summary
Since refiling to go public in November 2007, Aegerion Pharmaceuticals (cardiovascular and metabolic therapeutics) has gone ahead and raised an undisclosed amount of funding from inside investors to pay for current and upcoming clinical trials.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Private Placement
Already a Strategic Transactions subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
Advertisement
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Aegerion Pharmaceuticals raises funds
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice